How will the Broad Institute use its CRISPR patent now that

Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way

Related Keywords

Berkeley , California , United States , United Kingdom , Massachusetts , Boston , Cambridge , Cambridgeshire , Germany , Switzerland , Swiss , America , George Church , Ulrich Storz , Erick Lucera , Jacob Sherkow , Jennifer Doudna , Emmanuelle Charpentier , Feng Zhang , Vertex Pharmaceuticals , University Of California , Broad Institute , Max Planck Institute , University Of Illinois College Law , Editas Medicine , Illinois College , Crispr Patent , Vertex , Yeditas , Lawsuit ,